Inflammation, depression and dementia: Are they connected?

Neurochemical Research

Volumn 32, Issue 10, 2007, Pages 1749-1756

  Leonard, Brian E ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Cortisol; Macrophages; Microglia; Neurotoxicity; Pro inflammatory cytokines; Tryptophan kynurenine pathway

Indexed keywords

CYTOKINE; HYDROCORTISONE; NEUROTROPHIC FACTOR; NITRIC OXIDE; PROSTAGLANDIN E2;

ALZHEIMER DISEASE; DEGENERATIVE DISEASE; DEMENTIA; DEPRESSION; HUMAN; MICROGLIA; NERVE DEGENERATION; NEUROPROTECTION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; SYMPTOMATOLOGY;

ALZHEIMER DISEASE; DEMENTIA; DEPRESSIVE DISORDER; HUMANS; INFLAMMATION; NEUROTOXINS;

EID: 34548809845     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9385-y     Document Type: Review

References (82)

1. Leonard BE (1989) The amine hypothesis of depression: a reassessment. In: TiptonK F, Youdim MBH (eds) Biochemical and pharmacological aspects of depression. Taylor and Francis, London, pp 25-49
2. Brambilla F (2000) Psychoneuroendocriniligy: research on the pituitary-adrenal-cortical system. Psychosomat Med 62:576-607
3. Jonas BS, Laudo JF (2000) Negative affect as a prospective risk factor of hypertension. Psychosomat Med 62:188-196
4. Leonard BE (2006) Physical consequences of depression. Quart J mental Health 1:33-38
5. Herbert TB, Cohen S (1993) Depression and immunity: a meta-analytic view. Psychol Bull 113:472-486
6. Maes M (1999) Major depression and activation of the inflammatory response. Adv Exp Biol Med 461:25-46
7. Evans DL (2005) Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiat 58:175-189
8. Geerlings MI, Schoevers RA, Beckman AT et al (2000) Depression and risk of cognitive decline and Alzheimer's disease. Results of 2 prospective community based studies in the Netherlands. Br J Psychiat 176:568-575
9. Steffens DC, Plassman BL, Helms MJ et al (1997) A twin study of late onset depression and apolipoprotein E4 as risk factors for Alzheimer's disease. Biol Psychiat 41:851-856
10. Song C, Dinan TG, Leonard BE (1994) Changes in immunoglobulins, complement and acute phase proteins in depressed patients and normal controls. J Affect Dis 30:283-288
11. Ford DE, Erlinger TP (2004) Depression and C-reactive protein in U.S. adults. Arch Intern Med 164:1010-1014
12. Lanquillon S (2000) Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22:370-379
13. Levine J (2000) Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 40:171-176
14. Yu YW (2003) Association study of the IL-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology and antidepressant response. Neuropsychopharmacology 28:1182-1185
15. Jun TY (2003) Possible association between -G308A TNF alpha gene polymorphism and major depressive disorder in a Korean population. Psychiat Genet 13:179-181
16. Suarez EC (2004) Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation is associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinology 29:1119-1128
17. van der Ven A (2003) Herpes viruses,cytokines and altered haemostsis in vital exhaustion. Psychosomat Med 65:194-200
18. Leonard BE, Song C (2007) Stress, the immune system and depression. In: Encyclopedia of stress. Elsevier North Holland Press. (in press)
19. Haack M (1999) Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and depression. J Pdsychiat Res 33:407-418
20. Steptoe A (2003) Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle aged men and women. Psychol Med 33:667-674
21. Miller GE (2003) Pathways linking depression, adiposity and inflammatory markers in healthy young adults. Brain Behav Immun 17:276-285
22. Owen BM (2001) Raised levels of plasma IL-1 beta in major and post viral depression. Acta Psychiat Scand 103:226-228
23. Tiermeier H (2003) Inflammatory proteins and depression in the elderly. Epidemiology 14:103-107
24. Sluzewska A, Rybakowski J, Bosmans E. et al (1996) Indicators of immune activation in major depression. Psychiat Res 64:162-167
25. Myint A-M, Leonard BE, Steinbusch HW, Kim Y-K (2005) Thi, Th2 and Th3 cytokine alteratikons in major depression. J Affect Dis 88:169-173
26. Smith R (1991) The macrophage theory of depression. Med Hypoth 35:298-306
27. Wichers MC,Koek GH,Robaeys G et al (2005) IDO and interferon alpha induced'depressive symptoms: a shift in hypothesis from tryptophan depletion. Mol Psychiat 10:538-544
28. Meyers CA, Valentine AD (1995) Neurologic and psychiatric adverse effects of immunological therapy. CNS Drugs 3:56-68
29. Minden SL, Schiffer RB (1990) Affective disorder in multiple sclerosis. Gen Hosp Psychiatry 9:426-434
30. Marshall PS (1993) Allergy and depression: a neurochemical threshold model of the relation between the illnesses. Psychol Bull 113:23-43
31. Katon W, Sullivan MD (1990) Depression and chronic medical illness. J Clin Psychiatry 51:3-11
32. Schrott LM, Crnic LS (1996) Anxiety behavior, exploratory behavior and activitZBx and NZB F1 hybrid mice: role of genotype and autoimmune disease progression. Brain Behav Immun 10:260-274
33. Myint A-M, Kim Y-K (2003) Cytokine-serotonin interactions through indoleamine 2,3-dioxygenase: a neurodegenerative hypothesis of depression. Med Hypoth 61:519-525
34. Capuron L (2002) Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoin cytokine therapy. Mol Psychiat 7:468-473
35. Capuron L (2003) Association of exaggerated HPA axis response to the initial injection of IFN alpha with development of depression during IFN alpha therapy. Am J Psychiat 160:1342-1345
36. Juenling FD (2000) Prefrontal cortical hypometabolism during low dose IFN alpha treatment. Psychopharmacology 152:383-389
37. Capuron L (2005) Anterior cingulate activation and error processing during IFN alpha treatment. Biol Psychiatry 58:190-196
38. Cummings JL (2004) Alzheimer's disease. N Engl J Med 351:565-567
39. Selkoe DJ (2004) Alzheimer's disease: mechanistic understanding predictors novel therapies. Ann Intern Med 140:627-638
40. Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430:631-639
41. Hewett SJ, Csernansky CA, Choi DW (1994) Selective potentiation of NMDA induced neural injury following induction of astrocytic iNOS. Neuron 13:487-494
42. Song C, Horrobin DF, Leonard BE (2006) The comparison of changes in behaviour, neurochemistry, endocrine and immune functions after different routes, doses and durations of administration of IL-1 beta in rats. Pharmacopsychiatry 39:88-99
43. Herx LM, Rivest S, Young VW (2000) CNS initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor. J Immunol 165:2232-2239
44. Strjbos P, Rothwell N (1995) IL-1 beta attenuates excitatory amino acid neurodegeneration in vitro: involement of NGF. J Neurosci 15:3468-3474
45. Vandenabecle P, Fiers W (1991) Is amyloidogenesis during Alzheimer's disease due to an IL-1/IL-6 mediated acute phase reaction in the brain? Immunol Today 12:217-219
46. Grimaldi LM, Casadrei VM, Ferri C et al (2000) Association of early onset Alzheimer's disease with IL-1 alpha gene polymorphism. Ann Neurol 47:361-365
47. Meda L, Cassatella MA, Szendrei GI et al (1995) Activation of microglial cells bt beta amyloid protein and IFN gamma. Nature 374:647-650
48. Sciacca FL, Ferri C, Licastro F et al (2003) IL-1beta polymorphism is associated with age at onset of Alzheimer's disease. Neurobiol Aging 24:927-931
49. Norris JG, Benveniste EN (1993) IL-6 production by astrocytes: induction by norepinephrine. J Neuroimmunol 45:137-145
50. Ye SM, Johnson RW (1999) Increased IL-6 expression by microglia from brain of aged mice. J Neuroimmunol 93:139-148
51. Gradient RA, Otten V (1993) Differential expression of IL-6 and IL-6 receptor on RNA's in rat hypothalamus. Neurosci Lett 153:13-16
52. Qui Z, Sweeney DD, Netzeband JG, Grud DL (1998) Chronic IL-6 alters NMDA receptor mediated membrane responses and enhances neurotoxicity in developing CNS neurons. J Neurosci 18:10445-10456
53. Tarkowski E, Blennow K, Wallin A, Tarkowski A (1999) Intracerebral production of TNF alpha, a local neuroprotective agent, in Alzheimer's disease and vascular dementia. J Clin Immunol 19:223-230
54. Lanzem AS, Johnston CM, Perry VH et al (1998) Longitudinal study of inflammatory factors in serum, CSF and brain tissue in Alzheimer's disease: IL-1 beta, IL-6,IL-1 receptor antagonist, TNF alpha, soluble TNF receptors and alpha-chymotrypsin. Alzheim Dis Assoc Disord 12:215-227
55. Knezevic-Cuca J, Stansberry KB, Johnston G et al (2000) Neurotrophic role of IL-6 and soluble IL-6 receptor in NIE-115 neuroblastoma cells. J Neuroimmunol 102:8-16
56. Blasko I, Marx F, Steiner E et al (1999) TNF alpha plus IFN gamma induce production oif Alzheimer beta amyloid peptides and decrease secretion of amyloid precursor proteins. FASEB J 13:63-68
57. McCusker SM, Curran MD, Dynan KB et al (2001) Association between polymorphism in regulating region of gene encoding TNF alpha and risk of Alzheimer's disease and vascular dementia: a case controlled study. Lancet 357:436-439
58. Infante J, Llorca J, Berciano J, Combarros O (2002) No synergistic effect between 850 TNF alpha promoter polymorphism and APOE epsilon 4 allele in Alzheimer's disease. Neurosci Lett 328:71-73
59. Mitrasinovic OM, Perez GV, Zhao F et al (2001) Overexpression of macrophage colony stimulating factor receptor on microglial cells induces an inflammatory response. J biol Chem 276:30142-30149
60. Finch CE, Laping NJ, Morgan TE et al (1993) TGF beta 1 is an organiser of responses to neurodegeneration. J cell Biochem 53:314-322
61. Flanders KC, Ren RF, Lippa VCF (1998) TGF betas in neurodegenerative disease. Prog Neurobiol Biol Psychiatry 54:71-85
62. Kanne SM, Balota DA, Storandt M et al (1998) Relating anatomy to function in Alzheimer's disease: neuropsychological profiles predict regional neuropathology 5 years later. Neurol 50:979-985
63. Lyketos CG, Olin J (2002) Depression in Alzheimer's disease: overview and treatment. Biol Psychiatry 52:243-252
64. Rapp MA, Dahlman K, Sano M et al (2005) Neuropsychological differences between late onset and recurrent geriatric major depression. Am J Psychiatry 162:691-698
65. Guillemin GJ, Kerr SJ, Smythe GA et al (2001) The kynurenine pathway metabolism in human astrocytes: pathway for neuroprotection. J Neurochem 78:842-853
66. Hayaishi O Biochemical and medical aspects of tryptophan metabolism Elsevier: Amsterdam/North Holland Biomed (Press)
67. Kim JP, Choi DW (1987) Quinolinate neurotoxicity in cortical cell cultures. Neurosci 23:423-432
68. Stone TW, Darlington LG (2002) Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 1:609-620
69. Heyes MP, Achim CL, Wiley CA et al (1996) Human microglia convert l-tryptophan into neurotoxic quiolinic acid. Biochem J 320(pt.2):595-597
70. Butterfield DA, Casegna A, Lauderback CM, Drake J (2002) Evidence that amyloid beta peptide induced lipid peroxidation and its sequelae in Alzheimer's brain contribute to neural death. Neurobiol Aging 23:655-664
71. Heyes MP, Saito K, Major EO et al (1993) A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Brain 16:1425-1450
72. Markesberry WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23:134-147
73. Hartai Z, Juhasz A, Rimanoczy A et al Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease.Neurochem.Int.doi:10.1016/j.neuint. 2006.08.012
74. Leonard BE, Myint A-M (2006) Inflammation and depression: is there a causal connection with dementia? Neurotox Res 10:149-160
75. Vythingham M (2002) Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiat 159:2072-2080
76. Malberg JE, Eisch AJ, Nessler EJ, Duman RS (2000) Chronic antidepressant treatment imcreases neurogenesis in adult rat hippocampus. J Neurosci 20:9104-9110
77. Santarelli L (2003) Requirement of hippocampal neurogenesis for the behavioural effects of antidepressants. Science 301:805-809
78. Saivanen M, Lucas G, Emfors P et al (2005) BDNF and antidepressants have different but co-ordinated effects on neural turnoiver, proliferation and survival in the adult dendate gyrus. J Neurosci 25:1089-1094
79. Nibuya M, Takahashi M, Russell DS, Duman RS (1999) Chronic stress increases catalytic TrkB mRNA in rat hippocampus. Neurosci Lett 267:81-84
80. Vaidya VA, Siuciak JA, Du F, Duman RS (1999) Hippocampal mossy fibre sprouting induced by chronic ECS. Neurosci 898:157-166
81. Fujioka T, Fujioka A, Duman RS (2004) Activation of cAMP signalling facilitates the morphological maturation of new born neurons in adult hippocampus. J Neurosci 24:319-328
82. Song H, Poo M (2001) The cell biology of neuronal navigation. Nat Cell Biol 3:E81-E88